Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
- Klíčová slova
- Ascites, Biomarker, Cancer, diagnostics, MicroRNA, Plasma, Real-time PCR, Urine,
- MeSH
- ascites MeSH
- biologické markery MeSH
- cirkulující mikroRNA * MeSH
- krevní plazma chemie MeSH
- lidé MeSH
- mikro RNA * genetika MeSH
- nádorové biomarkery MeSH
- následné studie MeSH
- tělesné tekutiny * metabolismus MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biologické markery MeSH
- cirkulující mikroRNA * MeSH
- mikro RNA * MeSH
- nádorové biomarkery MeSH
MicroRNAs (miRNAs) comprise a large group of small noncoding RNAs within a heterogeneous entity of noncoding RNAs, forming potent functional tools regulating the crucial biological processes within cells and the body. Cell-free miRNAs have become one of the novel promising diagnostic, predictive, and prognostic biomarkers for various diseases extensively investigated in recent years. This is due to their presence within extracellular fractions of various body fluids suggesting their potential as noninvasive "liquid biopsy" in case of their dysregulated expression.Among the body fluids, blood plasma and serum along with urine are the most commonly investigated sources of various types of cell-free miRNAs. Another body fluid, i.e., ascites (effusion, peritoneal/pleural fluid) may be the clinically important fluid particularly associated with carcinogenesis in ovarian carcinomas and hepatocellular carcinomas or in case of liver cirrhosis.Here, we provide a protocol for an expression profiling study based on qPCR analyses aimed at finding novel candidate miRNAs via small-scale or large-scale screening and evaluation experiments using liquid biopsies of blood plasma, ascites, and urine. Using this approach may be worth in cases where no (or limited) information is available on miRNA expression in particular diseases and geographic regions, for validation of previously published miRNAs with promising diagnostic potential, particularly in situations where follow-up study is aimed at validating miRNAs coming from (micro) array or NGS experiments, or where funding for large-scale experiments is not available. We demonstrate that assessment of plasma, ascites, and urine miRNAs expression may represent a feasible method to explore the potential for finding novel diagnostic, predictive, and prognostic biomarkers for various diseases.
Zobrazit více v PubMed
Weber JA, Baxter DH, Zhang SL et al (2010) The MicroRNA Spectrum in 12 body fluids. Clin Chem 56:1733–1741 DOI
Záveský L, Jandáková E, Weinberger V et al (2022) Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers. Mol Biol Rep 49(3):1955–1971 DOI
Záveský L, Jandáková E, Weinberger V et al (2019) Ascites-derived extracellular microRNAs as potential biomarkers for ovarian cancer. Reprod Sci 26(4):510–522 DOI
Záveský L, Jandáková E, Weinberger V et al (2019) Ovarian cancer: differentially expressed microRNAs in tumor tissue and cell-free Ascitic fluid as potential novel biomarkers. Cancer Investig 37(9):440–452 DOI
Záveský L, Jandáková E, Weinberger V et al (2022) Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis. Cancer Biomark 33(1):1–16 DOI
Záveský L, Jandáková E, Turyna R et al (2015) Evaluation of cell-free urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers. A pilot study. Pathol Oncol Res 21(4):1027–1035 DOI
Záveský L, Jandáková E, Turyna R et al (2016) Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers. Neoplasma 63(1):121–132 DOI
Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:research0034.1 DOI
Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – excel-based tool using pair-wise correlations. Biotechnol Lett 26:509–515 DOI
Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of realtime quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250 DOI
